Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Dec 03, 2007 12:57pm
218 Views
Post# 13906738

RE: Threat to Alzheimer''''s drugs sparks fury

RE: Threat to Alzheimer''''s drugs sparks fury That is the quagmire in the States isn't it!! Not enough Gov. dollars going to AD at all. The current AD Drugs only help the memory a bit in a small percentage of the patient population. They do nothing to help with the cause. Still I doubt that they'll get away with what has been proposed. AZD-103 has such Compelling Pre-Clinical Data that Transition Therapeutics scored a $200,000,000.00 WorldWide Collaberation with ELAN with $15,000,000.00 UPFRONT. NOW PAID UP TO DATE!! Another $10,000,000.00 IS coming at the Start of the PHASEll Trial.......now not so far away at all. AD sufferers are a desperate lot.......it's a terrible terrible disease.
Bullboard Posts